Combined parasympathetic stimulation and drug therapy
View Patent ↗A method is provided for treating a subject, including applying a current to a site of the subject selected from the list consisting of: a vagus nerve of the subject, an epicardial fat pad of the subject, a pulmonary vein of the subject, a carotid artery of the subject, a carotid sinus of the subject, a vena cava vein of the subject, and an internal jugular vein of the subject. The method also includes configuring the current so as to treat a condition of the subject selected from the list consisting of: an autoimmune disease, an autoimmune inflammatory disease, multiple sclerosis, encephalitis, myelitis, immune-mediated neuropathy, myositis, dermatomyositis, polymyositis, inclusion body myositis, inflammatory demyelinating polyradiculoneuropathy, Guillain Barre syndrome, myasthenia gravis, inflammation of the nervous system, inflammatory bowel disease, Crohn's disease, ulcerative colitis, SLE (systemic lupus erythematosus), rheumatoid arthritis, vasculitis, polyarteritis nodosa, Sjogren syndrome, mixed connective tissue disease, glomerulonephritis, thyroid autoimmune disease, sepsis, meningitis, a bacterial infection, a viral infection, a fungal infection, sarcoidosis, hepatitis, and portal vein hypertension.
1. A method comprising:
administering, to a subject susceptible to bradycardia, a beta-blocker at a dosage lower than would normally be indicated for the subject;
applying a current to a site of the subject selected from the group of sites consisting of: a vagus nerve of the subject, an epicardial fat pad of the subject, a pulmonary vein of the subject, a carotid artery of the subject, a carotid sinus of the subject, a vena cava vein of the subject, and an internal jugular vein of the subject;
sensing a heart rate of the subject; and
upon detecting an occurrence of the bradycardia, terminating applying the current at least until a cessation of the bradycardia.
2. The method according to claim 1 , wherein applying the current comprises applying the current in respective bursts of pulses in each of a plurality of cardiac cycles of the subject.
3. The method according to claim 2 , wherein applying the current comprises synchronizing the bursts with a cardiac cycle of the subject.
4. The method according to claim 2 , wherein applying the current comprises applying a first pulse of each of the bursts after a delay from a sensed feature of an electrocardiogram (ECG) of the subject.
5. The method according to claim 2 , wherein applying the current comprises configuring each of the pulses to have a duration of between about 100 microseconds and about 2.5 milliseconds.
6. The method according to claim 1 , wherein applying the current comprises configuring the current so as to have an antiarrhythmic effect on an atrium of the subject.
7. The method according to claim 1 , wherein applying the current comprises configuring the current to inhibit propagation of naturally-generated efferent action potentials traveling through the site.
8. The method according to claim 7 , wherein applying the current comprises applying the current to the vagus nerve.
9. The method according to claim 1 , wherein the subject suffers from heart failure, and wherein administering comprises administering the beta-blocker to the subject suffering from the heart failure.
10. The method according to claim 1 , wherein applying the current comprises configuring the current at least in part responsively to the sensed heart rate.
11. The method according to claim 1 , wherein applying the current comprises configuring one or more parameters of the current so as to minimize a heart-rate-lowering effect of the applying of the current.